Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.

Slides:



Advertisements
Similar presentations
Max Sanam.  Understand stages in animal virus replication  Compare and contrast the multiplication cycle of DNA and RNA-containing animal viruses 
Advertisements

Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Associate professor in microbiology
Viruses are the smallest infectious diseases (ranging from nm) They are obligatory intracellular parasites without own metabolism (being parasites.
Viruses. Biology of Viruses Structure of Viruses: Size -Less then 0.2 microns Parts of the Virus 1)Capsid: -Made of protein subunits 2) Inner core: made.
Medical Microbiology Chapter 6 Viral Classification, Structure, and Replication.
Biochemistry of Hepatitis C
Flaviviridae Positive stranded RNA viruses. Flaviviridae Enveloped virions made up of a lipid bilayer with two or more types of envelope (E) glycoproteins.
19.09 Replication of HIV Slide number: 1
Domenico Sansonno, Franco Dammacco  The Lancet Infectious Diseases 
Virus Replication John Goulding, Imperial College London, UK
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Animal viruses/other infectious agents.
Example of viral growth cycles
PHARMACEUTICAL MICROBIOLOGY -1 PHT 226
Positive stranded RNA viruses
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus  Takasuke Fukuhara, Chikako Ono, Francesc Puig-Basagoiti, Yoshiharu.
Structural biology of hepatitis C virus
Hepatitis C Virus NS5A Protein–A Master Regulator?
Objectives To understand the general principles involved in RNA replication discussed in Chapter 6 pages To use the following + stranded RNA viruses.
VIRAL GENE EXPRESSION DR.SOBIA MANZOOR LECTURE 05.
Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
Hepatitis C virus infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
Figure 3 Life cycle of hepatitis E virus
HCV NS5A Inhibitors: The Devil Is in the Details
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
Figure 1 HCV life cycle and site of action of DAAs
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
Hepatitis C Virus NS5A Protein–A Master Regulator?
The Influenza Virus Enigma
N. Clementi, F. Cappelletti, E. Criscuolo, M. Castelli, N. Mancini, R
Viruses Dead or alive?.
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Packaged Genes – “Ready for Delivery”
Volume 44, Issue 2, Pages (February 2006)
Hepatitis C virus–cell interactions and their role in pathogenesis
Replication life cycle of HIV and sites of antiretroviral drug action.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Replication of human astroviruses.
Viruses Dead or alive?.
Hepatitis B and C virus-related carcinogenesis
Fig Chapter 19: VIRUS Figure 19.1 Are the tiny viruses infecting this E. coli cell alive? 0.5 µm.
Protein interactions during the flavivirus life cycle elucidated by MS-based proteomics. Protein interactions during the flavivirus life cycle elucidated.
The Neurobiology of Zika Virus
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
New therapies on the horizon for hepatitis C
Michael S. Diamond, Theodore C. Pierson  Cell 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India  P. Kumar  Clinical Microbiology and.
Life cycle of HCMV in a human cell.
N. Clementi, F. Cappelletti, E. Criscuolo, M. Castelli, N. Mancini, R
VIRUSES.
Cellular Networks Involved in the Influenza Virus Life Cycle
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
B19V infection of human erythroid progenitor cells (B19V life cycle).
Viruses.
Anti−Hepatitis C Virus Drugs in Development
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
J.L. Balcázar  Clinical Microbiology and Infection 
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
CMI readers' survey Clinical Microbiology and Infection
Understanding How Hepatitis C Virus Builds Its Unctuous Home
Schematic representation of the biogenesis of RV replication complexes
Production and Biomedical Application of Flavivirus-like Particles
The hantavirus life cycle.
Presentation transcript:

Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy  L.B. Dustin, B. Bartolini, M.R. Capobianchi, M. Pistello  Clinical Microbiology and Infection  Volume 22, Issue 10, Pages 826-832 (October 2016) DOI: 10.1016/j.cmi.2016.08.025 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 The hepatitis C virus (HCV) replication cycle. The seven steps of the viral life cycle, indicated in the white boxes, are the following: attachment—the viral particle, surrounded with lipoproteins, binds the target cells by interacting with several receptors some, most of which are shown in figure, considered essential and others accessory; entry—following attachment, the virus enters through clathrin-mediated endocytosis; uncoating—the cellular and viral membranes fuse and the capsid is disorganized with a process triggered by the low pH of the endosome. After uncoating, the positive-strand RNA genome is released into the cytoplasm; translation—the genomic RNA is directly translated in a polyprotein precursor that is then cleaved into single proteins by both host and viral proteases; replication—the non-structural proteins and some host factors form a replication complex that synthesized multiple copies of the HCV RNA genome via a minus-strand replicative intermediate; assembly and maturation—packaging of viral progeny takes place in the endoplasmic reticulum from which the virion acquires the envelope with E1 and E2 glycoproteins. Maturation and association with endogenous lipoproteins to form lipoviral particles immediately follow; release—virions are released from the cells most likely by exocytosis or transmitted to other cells via a cell-free mechanism. Clinical Microbiology and Infection 2016 22, 826-832DOI: (10.1016/j.cmi.2016.08.025) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 A schematic of the mutations conferring resistance to NS3, NS5A and NS5B inhibitors. Numbers refer to the amino acid positions correlated to resistance in various hepatitis C virus genotypes. Clinical Microbiology and Infection 2016 22, 826-832DOI: (10.1016/j.cmi.2016.08.025) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions